Bank of New York Mellon’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-53,733
| Closed | -$803K | – | 4511 |
|
|
2022
Q4 | $803K | Buy |
53,733
+37,582
| +233% | +$520K | ﹤0.01% | 3307 |
|
|
2022
Q3 | $133K | Buy |
+16,151
| New | +$124K | ﹤0.01% | 4141 |
|
|
2021
Q4 | – | Sell |
-12,564
| Closed | -$78K | – | 4731 |
|
|
2021
Q3 | $78K | Sell |
12,564
-8,020
| -39% | -$48K | ﹤0.01% | 4377 |
|
|
2021
Q2 | $136K | Sell |
20,584
-38,465
| -65% | -$265K | ﹤0.01% | 4170 |
|
|
2021
Q1 | $433K | Buy |
59,049
+436
| +0.7% | +$3.76K | ﹤0.01% | 3761 |
|
|
2020
Q4 | $339K | Buy |
58,613
+6,400
| +12% | +$36.6K | ﹤0.01% | 3781 |
|
|
2020
Q3 | $310K | Buy |
52,213
+9,780
| +23% | +$48.4K | ﹤0.01% | 3707 |
|
|
2020
Q2 | $218K | Buy |
+42,433
| New | +$268K | ﹤0.01% | 3777 |
|
|
2020
Q1 | – | Sell |
-9,812
| Closed | -$61K | – | 4235 |
|
|
2019
Q4 | $61K | Hold |
9,812
| – | – | ﹤0.01% | 4086 |
|
|
2019
Q3 | $83K | Hold |
9,812
| – | – | ﹤0.01% | 4051 |
|
|
2019
Q2 | $66K | Sell |
9,812
-30,665
| -76% | -$263K | ﹤0.01% | 4094 |
|
|
2019
Q1 | $332K | Sell |
40,477
-1,890
| -4% | -$19.5K | ﹤0.01% | 3714 |
|
|
2018
Q4 | $678K | Buy |
42,367
+9,266
| +28% | +$204K | ﹤0.01% | 3321 |
|
|
2018
Q3 | $1.1M | Buy |
33,101
+4,294
| +15% | +$110K | ﹤0.01% | 3217 |
|
|
2018
Q2 | $651K | Buy |
28,807
+21,206
| +279% | +$503K | ﹤0.01% | 3485 |
|
|
2018
Q1 | $220K | Sell |
7,601
-1,562
| -17% | -$45.7K | ﹤0.01% | 3908 |
|
|
2017
Q4 | $256K | Buy |
9,163
+2,628
| +40% | +$81.6K | ﹤0.01% | 3863 |
|
|
2017
Q3 | $239K | Sell |
6,535
-866
| -12% | -$26.8K | ﹤0.01% | 3821 |
|
|
2017
Q2 | $164K | Sell |
7,401
-1,185
| -14% | -$9.33K | ﹤0.01% | 3935 |
|
|
2017
Q1 | $51K | Buy |
8,586
+2,470
| +40% | +$17.8K | ﹤0.01% | 4135 |
|
|
2016
Q4 | $33K | Sell |
6,116
-423
| -6% | -$2.82K | ﹤0.01% | 4171 |
|
|
2016
Q3 | $58K | Sell |
6,539
-1,207
| -16% | -$11.4K | ﹤0.01% | 4120 |
|
|
2016
Q2 | $75K | Buy |
7,746
+71
| +0.9% | +$685 | ﹤0.01% | 4112 |
|
|
2016
Q1 | $71K | Buy |
7,675
+1
| +0% | +$10 | ﹤0.01% | 4032 |
|
|
2015
Q4 | $97K | Hold |
7,674
| – | – | ﹤0.01% | 4071 |
|
|
2015
Q3 | $93K | Sell |
7,674
-1
| -0% | -$14 | ﹤0.01% | 4130 |
|
|
2015
Q2 | $134K | Buy |
7,675
+1,051
| +16% | +$18.9K | ﹤0.01% | 3983 |
|
|
2015
Q1 | $96K | Hold |
6,624
| – | – | ﹤0.01% | 4050 |
|
|
2014
Q4 | $56K | Buy |
6,624
+5
| +0.1% | +$46 | ﹤0.01% | 4134 |
|
|
2014
Q3 | $73K | Hold |
6,619
| – | – | ﹤0.01% | 4118 |
|
|
2014
Q2 | $121K | Sell |
6,619
-16,693
| -72% | -$217K | ﹤0.01% | 3957 |
|
|
2014
Q1 | $348K | Sell |
23,312
-351
| -1% | -$6.3K | ﹤0.01% | 3690 |
|
|
2013
Q4 | $433K | Buy |
23,663
+299
| +1% | +$5.99K | ﹤0.01% | 3630 |
|
|
2013
Q3 | $482K | Sell |
23,364
-254
| -1% | -$5.82K | ﹤0.01% | 3538 |
|
|
2013
Q2 | $590K | Buy |
+23,618
| New | +$1.01M | ﹤0.01% | 3429 |
|
Bank of New York Mellon's AVEO Position: Q1 2023 in Review
Bank of New York Mellon sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 53,733 shares — an estimated $803K sold.
Bank of New York Mellon first reported a position in AVEO in Q2 2013 and held it in 35 quarters. The position peaked at $1.1M in Q3 2018. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- Bank of New York Mellon reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Bank of New York Mellon sold 53,733 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $803K.
- Bank of New York Mellon first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 35 quarters.
- Bank of New York Mellon's AVEO Pharmaceuticals, Inc. position peaked at $1.1M in Q3 2018.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on Bank of New York Mellon's 13F filing for Q1 2023, filed 9 May 2023.